Overview
Transient congenital hypothyroidism due to maternal factor is a temporary form of thyroid hormone deficiency present at birth that is caused by substances or conditions originating from the mother that cross the placenta and affect the newborn's thyroid function. The most common maternal factors include the transplacental passage of maternal thyrotropin receptor-blocking antibodies (TRBAb), maternal use of antithyroid medications (such as propylthiouracil or methimazole used to treat maternal Graves' disease or other hyperthyroid conditions), and excessive maternal iodine intake or deficiency. These maternal factors temporarily suppress the newborn's thyroid gland function, leading to reduced production of thyroid hormones (T3 and T4) and elevated thyroid-stimulating hormone (TSH) levels. Affected newborns may present with clinical features typical of congenital hypothyroidism, including prolonged jaundice, feeding difficulties, constipation, hypotonia (decreased muscle tone), large fontanelles, macroglossia (enlarged tongue), dry skin, hypothermia, and lethargy. If untreated, even transient hypothyroidism during the critical neonatal period can impair neurodevelopment. The condition is typically detected through newborn screening programs that measure TSH and/or T4 levels. The key distinguishing feature of this condition is its transient nature — once the maternal factor is cleared from the infant's circulation (typically within weeks to a few months), normal thyroid function is restored. Treatment involves levothyroxine (synthetic thyroid hormone) replacement therapy initiated promptly after diagnosis to ensure normal growth and neurodevelopment during the critical early postnatal period. Therapy is typically continued until the maternal factor has been cleared, after which thyroid function is reassessed. A trial off medication is usually attempted around 2–3 years of age (or earlier if the transient etiology is confirmed) to verify recovery of normal thyroid function. Maternal history, including thyroid disease status and medication use, is essential for establishing the diagnosis and distinguishing this transient form from permanent congenital hypothyroidism.
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
1 availableClotic
treatment of fungal otitis externa (otomycosis) due to Aspergillus species and Candida species in patients 18 years of age and older
Clinical Trials
View all trials with filters →No actively recruiting trials found for Transient congenital hypothyroidism due to maternal factor at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Transient congenital hypothyroidism due to maternal factor.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Transient congenital hypothyroidism due to maternal factor.
Community
No community posts yet. Be the first to share your experience with Transient congenital hypothyroidism due to maternal factor.
Start the conversation →Latest news about Transient congenital hypothyroidism due to maternal factor
No recent news articles for Transient congenital hypothyroidism due to maternal factor.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Transient congenital hypothyroidism due to maternal factor
What is Transient congenital hypothyroidism due to maternal factor?
Transient congenital hypothyroidism due to maternal factor is a temporary form of thyroid hormone deficiency present at birth that is caused by substances or conditions originating from the mother that cross the placenta and affect the newborn's thyroid function. The most common maternal factors include the transplacental passage of maternal thyrotropin receptor-blocking antibodies (TRBAb), maternal use of antithyroid medications (such as propylthiouracil or methimazole used to treat maternal Graves' disease or other hyperthyroid conditions), and excessive maternal iodine intake or deficiency.
At what age does Transient congenital hypothyroidism due to maternal factor typically begin?
Typical onset of Transient congenital hypothyroidism due to maternal factor is neonatal. Age of onset can vary across affected individuals.
What treatment and support options exist for Transient congenital hypothyroidism due to maternal factor?
1 patient support program are currently tracked on UniteRare for Transient congenital hypothyroidism due to maternal factor. See the treatments and support programs sections for copay assistance, eligibility, and contact details.